Sign up for HER connection- HER connection
Discover a program designed to support patients with knowledge and information about HER2+ breast cancer.
Three ways to connect:
Receive Updates
Personalized information to support your treatment
Support Line
Call 866.449.HER2 Nurses available 24/7
Online Live Chat
Nurses available Monday-Friday, 8am EST to 8pm EST.
All for HER
When going through a difficult time, nurses can be the backbone of your support system. This list is made up of the men and women who make a difference in the lives of patients facing HER+ Breast cancer. Nomiees are listed by region.
- 2008 All for HER Winners
-
- Tara Gehrig
- 2008 Central Winner
- University of Chicago Medical Center
- Chicago, IL
- Disease State: Adjuvant
-
- Nancy Sokolowski
- 2008 North East Winner
- Whittingham Cancer Center / Smilow Breast Center
- Norwalk, CT
- Disease State: Adjuvant
-
- Suzanne Perez
- 2008 South Winner
- Lester and Sue Smith Breast Center
- Houston, TX
- Disease State: Adjuvant and Metastatic
-
- Susan Gardner
- 2008 West Winner
- Swedish Breast Center
- Seattle, WA
- Disease State: Adjuvant and Metastatic
2008 All For Her Central Nominees
- Amanda Hettinga, Muncie, IN
- Andrea Dracon, Westlake, OH
- Annamarie Holt, Warren, OH
- Barbara Church, Muncie, IN
- Beth Staggs, Muncie, IN
- Cynthia Marsack, Dearborn, MI
- Debbie Dorman, Muncie, IN
- Faye Gibson, Joplin, MO
- Gail Johnson, Cincinnati, OH
- Jodi Wendel, Muncie, IN
- Judith Hatch, Lexington, KY
- Karen Grooms, Indianapolis, IN
- Kelly Paulie, Sprinfield, MO
- Laura Cuevas, Milwaukee, WI
- Linda Watson, Gallipolis, OH
- Lisa Ann Christian, Kitts Hill, OH
- Lora Dequeredo, Chicago, IL
- Marjorie Wiseman, Muncie, IN
- Mary Mulcahy, Chillicothe, OH
- Molly Loney, Mayfield Hghts, OH
- Niels Billund, Edina, MN
- Patricia Dolack, Louisville, KY
- Shari Heinen, Glencoe, MN
- Sherri Papp, Muncie, IN
- Sue Huss, Rolla, MO
- Susan Furtwengler, Cincinnati, OH
- Tara Gehrig, Chicago, IL
- Vanessa Reyes, Southfield, MI
- Rose Casal, Mayfield Hghts, OH
- Becky Deangelo, Mount Vernon, OH
- Barbara Moss, Canton, OH
- Linda Sainsbury, Buffalo, MN
- Diane Nechi-Fragassi, Highland Park, IL
- Amy Carol Bebee, Joplin, MO
2008 All For Her North East Nominees
- Albano Loryn, Hackensack, NJ
- Alice Veitz, Wayne, PA
- Connie Miller, Lynchburg, VA
- Deborah Danko, Corning, NY
- Elizabeth Brown, Barnegat, NJ
- Fran Necci, Brooklyn, NY
- Heather Coelho, Providence, RI
- Jessi Von Bank, Reston, VA
- Kathleen Schwert, Buffalo, NY
- Kathleen Wegrzyn, Media, PA
- Kitty Forbush, Rochester, NY
- Linda Pollio, Lake Success, NY
- Mandy Jaconski, Bethlehem, PA
- Marie Walton, Philadelphia, PA
- Mary Ann, Juliano New York, NY
- Mary Ellen Vanuitter, Staten Island, NY
- Michelle MacKenzie, Morristown, NJ
- Nancy Sokolowski, Norwalk, CT
- Patricia Flynn, Brooklyn, NY
- Susan Frederick-Hodes, Rochester, NY
- Susan Tomberg, Springfield, VT
- Toni Graham, Concord, NC
- Linda Paugh, Elmira, NY
2008 All For Her South Nominees
- Carmen Espada, Orlando, FL
- Catherine Baravski, Ft Lauderdale, FL
- Cicely Scarlett, Houston, TX
- Cindy Lawson, San Antonio, TX
- Claudia Giddings, Atlanta, GA
- Colleen Butcher, Charleston, SC
- Cynthia Beaty, Greenwood, SC
- Debbie Killen, Franklin, KY
- Francis Brown, Houston, TX
- Heather Bain, Hollywood, FL
- Holly Books, Austin, TX
- Jan Edwards, Augusta, GA
- Jane Bryant, Florence, SC
- Janequa NcKnight, Charleston, SC
- Kate Carlson, Atlanta, GA
- Kelly Jeffcoat, West Columbia, SC
- Lesa Stancill, Dalton, GA
- Luanne Laine, Lebanon, TN
- Lyn Wulf, Boca Raton, FL
- Maricarmen Alverado, San Juan, Puerto Rico
- May West, Houston, TX
- Nina Trent, Greenwood, SC
- Philomena Doliny, Miami, FL
- Sherree Bennett, Fort Worth, TX
- Suzanne Perez, Houston, TX
- Teri McNeill, Jupiter, FL
- Wendy Greene, Charleston, SC
- Michelle Van Putten, Hollywood, FL
- Karen Devries, New York, NY
- Kay Washington, Nacogdoches, TX
- Cheryl Casell-Avno, Hollywood, FL
- Lucy Finney, Atlanta, GA
2008 All For Her West Nominees
- Jeff Brostrom, Olympia, WA
- Adrian Johnson, Encinitas, CA
- Andrea Cox, Albuquerque, NM
- Carrie McGillivray, Sandpoint, ID
- Cheri Uehara, Honolulu, HI
- Deena Lonzo, Evertt, WA
- Donna Pekera, Scottsdale, AZ
- Eilleen Ashley, Travis, CA
- Elizabeth Elliott, Santa Maria, CA
- Felicia Barrientos, Encinitas, CA
- Hope Gutierrez, Rancho Cucamonga, CA
- Jane Greer-Kuchar, Fresno, CA
- Janis Jewell, Lacey, WA
- Jeannine Vedera, Seattle, WA
- Jodi Darnett, Boulder, CO
- Julie Hooper, Longview, WA
- Karen Aron, Truckee, CA
- Lisa Felber, Seattle, WA
- Margaret Hills, Bremerton, WA
- Margaret Randel, Albuquerque, NM
- Patricia Buker, Olympia, WA
- Penny Hill, Roseville, CA
- Susan Gardner, Seattle, WA
- Tressa Petzinger, Encinitas, CA
- Lana McCallum, Greely, CO
- Diane Ball, Reno, NV
- Sima Nazi, Modesto, CA
- Denice Gibson, Phoenix, AZ
Who is Herceptin for?
Herceptin is approved for the adjuvant treatment of HER2-overexpressing, node-positive or node-negative (ER/PR-negative or with one high-risk feature)† breast cancer. Herceptin can be used several different ways:
- As part of a treatment regimen including doxorubicin, cyclophosphamide, and either paclitaxel or docetaxel
- With docetaxel and carboplatin
- As a single agent following multi-modality anthracycline-based therapy
Herceptin in combination with paclitaxel is approved for the first-line treatment of HER2-overexpressing metastatic breast cancer. Herceptin as a single agent is approved for treatment of HER2-overexpressing breast cancer in patients who have received one or more chemotherapy regimens for metastatic disease.
† High-risk is defined as ER/PR positive with one of the following features: tumor size >2 cm, age <35 years, or tumor grade 2 or 3.
What important safety information should I know about Herceptin?
Herceptin treatment can result in heart problems, including those without symptoms (reduced heart function) and those with symptoms (congestive heart failure). The risk and seriousness of these heart problems were highest in people who received both Herceptin and a certain type of chemotherapy (anthracycline). Your doctor will stop or strongly consider stopping Herceptin if you have a significant drop in your heart function.
You should be monitored for decreased heart function before your first dose of Herceptin, and frequently during the time you are receiving Herceptin and after your last dose of Herceptin. If you must permanently or temporarily stop Herceptin due to heart problems, you should be monitored more frequently. In one study with Herceptin and certain types of chemotherapy, an inadequate blood supply to the heart occurred.
Some patients have had serious infusion reactions and lung problems; fatal infusion reactions have been reported. In most cases, these reactions occurred during or within 24 hours of receiving Herceptin. Your Herceptin infusion should be temporarily stopped if you have shortness of breath or very low blood pressure. Your doctor will monitor you until these symptoms go away. If you have a severe allergic reaction, swelling, lung problems, inflammation of the lung, or severe shortness of breath, your doctor may need to completely stop your Herceptin treatment.
Worsening of low white blood cell counts associated with chemotherapy has also occurred.
Herceptin can cause low amniotic fluid levels and harm to the fetus when taken by a pregnant woman.
The most common side effects associated with Herceptin were fever, nausea, vomiting, infusion reactions, diarrhea, infections, increased cough, headache, fatigue, shortness of breath, rash, low white and red blood cells, and muscle pain.
Because everyone is different, it is not possible to predict what side effects any one person will have. If you have questions or concerns about side effects, talk to your doctor.
Please see the Herceptin full Prescribing Information including Boxed WARNINGS and additional important safety information.
Herceptin® (trastuzumab)
- Home
- HER2 and Breast Cancer Education
- Adjuvant Treatment
- Metastatic Treatment
- Community
- Resource Center
- What do Adjuvant and Metastatic mean? Learn more.
Adjuvant Care Is defined as additional treatment given after the main treatment plan to decrease the chance of recurrence. Adjuvant therapy for breast cancer can include chemotherapy, hormone therapy, radiation therapy, or biological therapy
Metastatic Breast Cancer Breast cancer that has spread to other sites in the body; also referred to as invasive or infiltrating
